How Merck uses patents to help maintain Keytruda’s exorbitant price October 7, 2026 MMN Editor Filed Under: Commentary Culture InvestigationsExplore the U.S. patents Merck deploys to stymie competition and keep revenues for its blockbuster cancer drug flowing as long as possible.